%0 Journal Article
%K Male
%K Humans
%K Female
%K Aged
%K *Osteoporotic Fractures/epidemiology
%K Cost-Effectiveness Analysis
%K *Cardiovascular Diseases/drug therapy
%K *Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
%K Diphosphonates/therapeutic use
%B Health Soc Care Deliv Res
%D 2024
%G eng
%M 38420962
%P 1-275
%R 10.3310/kltr7714
%T The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis
%V 12
%7 2024/02/29
%@ 2755-0060